Specialty biotech developing the next generation of inhaled therapies for such conditions as #cysticfibrosis #COPD & idiopathic pulmonary fibrosis.

Biotechnology

Pulmatrix

Pulmatrix's headquarters in Lexington, MA, United States

Margaret Wasilewski

Peter Ludlum

Valielza O’Keefe

Chris Cabell

Rick Batycky

William J. Calhoun

Ritesh Agarwal

Mario Castro

Jonathan Corren

David Denning

Cendrine Godet

Richard B. Moss

Russell A. Settipane

David A. Stevens

Michael E Wechsler

Rusty Clayton

Michael J. Higgins

Mark Iwicki

The Advisory Roles team at Pulmatrix comprises experienced professionals who provide strategic guidance and expertise in clinical development, regulatory affairs, and manufacturing processes. Their collective insights help shape the direction of inhaled therapies for conditions such as cystic fibrosis, COPD, and idiopathic pulmonary fibrosis, ensuring that the company remains at the forefront of innovation and compliance in the biotech industry.

Advisory Roles

This department orchestrates strategic vision and decision-making at the highest organizational level.

Executive Leadership

This department oversees the management and strategic direction of the organization through its board members.

Board Governance

The Leadership Team at Pulmatrix plays a pivotal role in guiding the company’s strategic direction and operational execution in the development of innovative inhaled therapies. Composed of key executives, including the Chief Medical Officer and Vice Presidents of Quality and CMC & Pharmaceutical Development, they collaborate to ensure that clinical, regulatory, and manufacturing objectives align with the company’s mission to address respiratory diseases like cystic fibrosis and COPD. Their expertise drives decision-making, resource allocation, and fosters a culture of excellence within the organization.

Leadership Team

The Research and Development team at Pulmatrix is dedicated to innovating and advancing inhaled therapies for respiratory conditions such as cystic fibrosis, COPD, and idiopathic pulmonary fibrosis. Led by the Director of Pharmaceutical Development, the team leverages cutting-edge scientific research and data analysis to develop, test, and optimize novel formulations and delivery methods, ensuring safe and effective treatments for patients. Collaborating closely, the Senior Scientist and Research Associate contribute to experimental design, data collection, and the progression of projects from concept to clinical evaluation.

Pulmatrix

Org chart

Board & advisors

Teams

Advisory Roles

Executive Leadership

Board Governance

Leadership Team

Research and Development

Offices

Pulmatrix

Org chart

Board & advisors

Teams

Advisory Roles

Executive Leadership

Board Governance

Leadership Team

Research and Development

Offices

Related companies